Study on the evaluation of the efficacy of Chinese medicine to prevent recurrence of ischemic stroke stroke in China

at present, theof Chinese medicine inischemic stroke in China is widely used in clinical treatment, but because of the lack of Chinese medicine in line with the internationalstandards
the efficacy evaluation, its effectiveness is not recognized by the international medical communityWith the launch and implementation of a large-scale study on the evaluation of the efficacy of chinese medicine to prevent ischemic stroke recurrence organized by the State Administration of Traditional Chinese Medicine, the helpless situation of the Chinese medicine industry is expected to changeRecently, from theof China 2
9 provinces, autonomous regions, municipalities directly under the Central Government of the2
59 to comprehensive Westernhospitals-based medical and health institutions 497 experts to participate in the "Eleventh Five-Year Plan" National Science and Technology Support Plan - "Chinese medicine lamp pulse capsule intervention ischemic stroke secondary prevention clinical trial" research launched in KunmingThe purpose of this study is to evaluate the effectiveness of Chinese medicine to prevent the recurrence of ischemic stroke with theof international medicalstandards, and to promote Chinese medicine to the worldAccording to Sun Xianglun, director of the "11th Five-Year Plan" support program of the State Administration of Traditional Chinese Medicine, the incidence of stroke in China is much higher than in Western countries, and the characteristics of high mortality , high recurrence rate of ,
high disability rate In the treatment of ischemic stroke, commonly known as "brain infarction", it is very important to prevent the recurrence of patients, the mortality rate and disability rate of recurrent cerebral infarction is significantly higher than that of the first onset of patients, and the health of the people's lives is more harmful , professor of Guangzhou University of Traditional Chinese Medicine, , said that Chinese medicine in China ischemic stroke treatment of clinical applications accounted for more than 60%, but because of the lack of international lysis in accordance with the modern evidence-based medical standards of clinical research, at present in the field of ischemic stroke secondary prevention, domestic and foreign recognized effective drugs are Western medicine To this end, the research project, jointly undertaken by Guangzhou University of Traditional Chinese Medicine and Chengdu University of Traditional Chinese Medicine, identified the of clinical studies using randomized double-blind methods , placebo-controlled , multi-center , and large samples, to ensure that the results met the requirements of the a-level Evidence Strength of Modern Evidence-Based Medicine it is understood the in accordance with international practice, the study has been registered with Clinical Trial in the United States Huang Yan said , no matter how the results of the test, the start-up and implementation of this research shows that China's traditional Chinese medicine is gradually moving towards independent innovation, and Western medicine to learn from each other's bright future